The latest Phase 3 trial results for Immunovant’s batoclimab drug showed achieve...
Opko Health and Entera Bio have formally announced their collaboration as the bi...
Taiho Pharmaceutical has paid Otsuka $400 million in upfront purchase of the Ara...
A young patient diagnosed with Duchenne muscular dystrophy has passed away follo...
GSK’s ViiV Healthcare has disclosed clinical data about three prospective long-a...
Hologen AI has pledged up to $430 million through a strategic partnership to sup...
After almost a decade of contending with bankruptcy filings and opioid settlemen...
Roche has committed to an initial payment of $1.65 billion to enhance its growin...
Johnson & Johnson has contributed to the ongoing issues surrounding opioids. Mon...
Daiichi Sankyo has taken a step forward in expanding its interest in RNA-based t...
Pfizer and Arvinas reported that their estrogen receptor degrader failed to meet...
Merck has inaugurated a fresh $1 billion, 225,000-square-foot manufacturing site...
China-based Harbour BioMed has recently announced the establishment of a new bio...
The Durham complex of Merck now operates a new $1 billion, massive 225,000-squar...
Merck KGaA has faced a challenge in the clinical evaluation of its investigation...
The phase 1 T-cell engager developed by Amgen and CytomX Therapeutics was termin...
